IGF2BP2 and colorectal carcinoma: In human CRC cells, IMP2 overexpression was accompanied by elevated m6A modification and ZFAS1 expression, resulting in cell proliferative promotion and cellular apoptotic inhibition by stabilizing m6A-modified ZFAS1.